CYMBALTA
Live / Registered — Registered and renewed (as of 30 Apr 2024)
What this means for you
Registered since 06 Jan 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Jan 2024).
Record
- Serial number
- 75867543
- Registration number
- 2802665
- Mark type
- Word mark
- Filed
- 09 Dec 1999
- Published for opposition
- 01 Aug 2000
- Registered
- 06 Jan 2004
- Next maintenance due
- 06 Jan 2024
- Attorney of record
- BRUCE W. LONGBOTTOM
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and medicinal preparations for treatment of diseases and disorders of the central nervous system
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 30 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 30 Apr 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 30 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jan 2024 — TEAS SECTION 8 & 9 RECEIVED
- 06 Jan 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Dec 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Dec 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Dec 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Dec 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 16 Dec 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Dec 2013 — TEAS SECTION 8 & 9 RECEIVED
- 09 Jan 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Jan 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2010 — TEAS SECTION 8 & 15 RECEIVED